Ebert, Benjamin L.
Broad Institute,
United States
2025 Rank: 7155
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 151 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7155 | 7448 |
| Total Cites | 11741 | 12672 |
| H-index | 39 | 41 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 51 | 51 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 2654 | 2895 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8885 | 9146 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.39 |
| Self-Citation Percentage |
7.35%
|
|
Ebert, Benjamin L.
Dana-Farber Cancer Institute,
United States
2024 Rank: 6406
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 157 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6406 | 6504 |
| Total Cites | 11462 | 12341 |
| H-index | 40 | 43 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 50 | 50 |
| Number of Single+First+Last Authored Papers | 136 | 136 |
| Total Cites to Single+First+Last Authored Papers | 2585 | 2798 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8816 | 9079 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.36 |
| Self-Citation Percentage |
7.12%
|
|
Ebert, Benjamin L.
Dana-Farber Cancer Institute,
United States
2023 Rank: 5946
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 152 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5946 | 5488 |
| Total Cites | 10982 | 11642 |
| H-index | 39 | 42 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 7 | 9 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 74 | 79 |
| Number of Single+First+Last Authored Papers | 132 | 132 |
| Total Cites to Single+First+Last Authored Papers | 2569 | 2808 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8862 | 9079 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
5.67%
|
|
Ebert, Benjamin L.
Howard Hughes Medical Institute,
United States
2022 Rank: 4765
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 137 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4765 | 5071 |
| Total Cites | 10487 | 10988 |
| H-index | 40 | 41 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 94 | 95 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 2658 | 2837 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8489 | 8690 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
4.56%
|
|
Ebert, Benjamin L.
Howard Hughes Medical Institute,
United States
2021 Rank: 6511
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 170 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6511 | 6940 |
| Total Cites | 14075 | 14804 |
| H-index | 40 | 43 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 116 | 120 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 3640 | 3928 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11538 | 11835 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
4.92%
|
|
Ebert, Benjamin L.
Dana-Farber Cancer Institute,
United States
2020 Rank: 7422
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 178 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7422 | 8026 |
| Total Cites | 9284 | 9801 |
| H-index | 33 | 35 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 103 | 105 |
| Number of Single+First+Last Authored Papers | 101 | 101 |
| Total Cites to Single+First+Last Authored Papers | 2421 | 2619 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7673 | 7883 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.24 |
| Self-Citation Percentage |
5.27%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.